1Wheller DC, Persaud. Receptor mediated binding of human low density lipoprotein to rat mesangial cell in vitro. Kidney Int,1989,35:439.
2Appel G, Fert J. Lipid abnormalities in renal disease. Kidney Int, 1991,39: 169.
3Grone EF, Abboud HE, Hobne M, et al. Actions of lipoproteins in cultured human mesangial cells: modulation by mitogenic vasoconstrictors. Am J Physiol, 1992,263:686 - 696.
4Rovin BH, Tan LC. LDL stimulates mesangial fibronectin production and chemoattractant expression. Kidney Int, 1993, 43:218 - 225.
5Detlef S, Chlondorff. Mechanism of lipid injury in the glomerulus. Am J Kidney Dis, 1993,22( 1 ) :72 - 82.
6Rovin BH, Lefkowit JB. Mechanisms underlying the anti- infiammatory effects of essential fatty acid seficiency in experimental glomerulonephritis. J Immunol, 1990, 145: 1238.
7D' Amico G, Gentile MG. Influence of diet on lipid abnormalities in human renal disease. Am J Kidney Dis, 1993,22:151 - 157.
8Han DC, Biswas SD, Hwang SD, et al. Lovastatin prevents glomerulosclerosis in STZ- induced diabetic uniniphrectomized rats. Kidney Int, 1993,44:1181.
